Ilufredo Y Tantoy1, Bruce A Cooper1, Anand Dhruva2, Janine Cataldo1, Steven M Paul1, Yvette P Conley3, Marilyn Hammer4, Fay Wright5, Laura B Dunn6, Jon D Levine2, Christine Miaskowski7. 1. School of Nursing, University of California, San Francisco, California, USA. 2. School of Medicine, University of California, San Francisco, California, USA. 3. School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 4. Department of Nursing, Mount Sinai Medical Center, New York, New York, USA. 5. School of Nursing, Yale University, New Haven, Connecticut, USA. 6. School of Medicine, Stanford University, Palo Alto, California, USA. 7. School of Nursing, University of California, San Francisco, California, USA. Electronic address: chris.miaskowski@ucsf.edu.
Abstract
CONTEXT: Studies on multiple dimensions of the symptom experience of patients with gastrointestinal cancers are extremely limited. OBJECTIVE: Purpose was to evaluate for changes over time in the occurrence, severity, and distress of seven common symptoms in these patients. METHODS: Patients completed Memorial Symptom Assessment Scale, six times over two cycles of chemotherapy (CTX). Changes over time in occurrence, severity, and distress of pain, lack of energy, nausea, feeling drowsy, difficulty sleeping, and change in the way food tastes were evaluated using multilevel regression analyses. In the conditional models, effects of treatment group (i.e., with or without targeted therapy), age, number of metastatic sites, time from cancer diagnosis, number of prior cancer treatments, cancer diagnosis, and CTX regimen on enrollment levels, as well as the trajectories of symptom occurrence, severity, and distress were evaluated. RESULTS: Although the occurrence rates for pain, lack of energy, feeling drowsy, difficulty sleeping, and change in the way food tastes declined over the two cycles of CTX, nausea and numbness/tingling in hands/feet had more complex patterns of occurrence. Severity and distress ratings for the seven symptoms varied across the two cycles of CTX. CONCLUSIONS: Demographic and clinical characteristics associated with differences in enrollment levels as well as changes over time in occurrence, severity, and distress of these seven common symptoms were highly variable. These findings can be used to identify patients who are at higher risk for more severe and distressing symptoms during CTX and to enable the initiation of preemptive symptom management interventions.
CONTEXT: Studies on multiple dimensions of the symptom experience of patients with gastrointestinal cancers are extremely limited. OBJECTIVE: Purpose was to evaluate for changes over time in the occurrence, severity, and distress of seven common symptoms in these patients. METHODS:Patients completed Memorial Symptom Assessment Scale, six times over two cycles of chemotherapy (CTX). Changes over time in occurrence, severity, and distress of pain, lack of energy, nausea, feeling drowsy, difficulty sleeping, and change in the way food tastes were evaluated using multilevel regression analyses. In the conditional models, effects of treatment group (i.e., with or without targeted therapy), age, number of metastatic sites, time from cancer diagnosis, number of prior cancer treatments, cancer diagnosis, and CTX regimen on enrollment levels, as well as the trajectories of symptom occurrence, severity, and distress were evaluated. RESULTS: Although the occurrence rates for pain, lack of energy, feeling drowsy, difficulty sleeping, and change in the way food tastes declined over the two cycles of CTX, nausea and numbness/tingling in hands/feet had more complex patterns of occurrence. Severity and distress ratings for the seven symptoms varied across the two cycles of CTX. CONCLUSIONS: Demographic and clinical characteristics associated with differences in enrollment levels as well as changes over time in occurrence, severity, and distress of these seven common symptoms were highly variable. These findings can be used to identify patients who are at higher risk for more severe and distressing symptoms during CTX and to enable the initiation of preemptive symptom management interventions.
Authors: Marta Seretny; Gillian L Currie; Emily S Sena; Sabrina Ramnarine; Robin Grant; Malcolm R MacLeod; Leslie A Colvin; Marie Fallon Journal: Pain Date: 2014-09-23 Impact factor: 6.961
Authors: Fay Wright; Gail D'Eramo Melkus; Marilyn Hammer; Brian L Schmidt; M Tish Knobf; Steven M Paul; Frances Cartwright; Judy Mastick; Bruce A Cooper; Lee-May Chen; Michelle Melisko; Jon D Levine; Kord Kober; Bradley E Aouizerat; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2015-03-28 Impact factor: 3.612
Authors: Fay Wright; Gail D'Eramo Melkus; Marilyn Hammer; Brian L Schmidt; M Tish Knobf; Steven M Paul; Frances Cartwright; Judy Mastick; Bruce A Cooper; Lee-May Chen; Michelle Melisko; Jon D Levine; Kord Kober; Bradley E Aouizerat; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2015-03-28 Impact factor: 3.612
Authors: Eva-Maria Gamper; Johannes Maria Giesinger; Anne Oberguggenberger; Georg Kemmler; Lisa Maria Wintner; Klaus Gattringer; Barbara Sperner-Unterweger; Bernhard Holzner; August Zabernigg Journal: Acta Oncol Date: 2011-11-30 Impact factor: 4.089
Authors: Alissa Nolden; Paule V Joseph; Kord M Kober; Bruce A Cooper; Steven M Paul; Marilyn J Hammer; Laura B Dunn; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2019-07-23 Impact factor: 3.612
Authors: Kathleen T Hickey; Suzanne Bakken; Mary W Byrne; Donald Chip E Bailey; George Demiris; Sharron L Docherty; Susan G Dorsey; Barbara J Guthrie; Margaret M Heitkemper; Cynthia S Jacelon; Teresa J Kelechi; Shirley M Moore; Nancy S Redeker; Cynthia L Renn; Barbara Resnick; Angela Starkweather; Hilaire Thompson; Teresa M Ward; Donna Jo McCloskey; Joan K Austin; Patricia A Grady Journal: Nurs Outlook Date: 2019-01-18 Impact factor: 3.250
Authors: Catherine E Mosher; Ekin Secinti; Wei Wu; Deborah A Kashy; Kurt Kroenke; Jonathan B Bricker; Paul R Helft; Anita A Turk; Patrick J Loehrer; Amikar Sehdev; Ahmad A Al-Hader; Victoria L Champion; Shelley A Johns Journal: Palliat Med Date: 2022-05-30 Impact factor: 5.713
Authors: Yufen Lin; Donald E Bailey; Sharron L Docherty; Laura S Porter; Bruce A Cooper; Steven M Paul; Kord M Kober; Marilyn J Hammer; Fay Wright; Laura B Dunn; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Support Care Cancer Date: 2021-01-16 Impact factor: 3.359
Authors: Sara Moazzen; Francisco O Cortés-Ibañez; Barbara L van Leeuwen; Behrooz Z Alizadeh; Geertruida H de Bock Journal: Nutrients Date: 2020-07-27 Impact factor: 5.717
Authors: Winnie K W So; Bernard M H Law; Marques S N Ng; Xiaole He; Dorothy N S Chan; Carmen W H Chan; Alexandra L McCarthy Journal: Cancer Med Date: 2021-03-21 Impact factor: 4.452